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A NOTE FROM THE EDITOR
A Uniform Clinical Trial Registration Policy for Journals of
Kidney Diseases, Dialysis, and Transplantation
Medical research can be seriously compromised by the
selective publication of clinical trial results. Therefore,
it is imperative that information regarding clinical trials
should be available to the general public.
We require, as a condition of consideration for publi-
cation, registration in a public trials registry. Trials must
register at or before the onset of patient enrollment. This
policy applies to any clinical trial starting enrollment after
January 1, 2006. For trials that began enrollment before
this date, we require registration by April 1, 2006, before
considering the trial for publication.
We define a clinical trial as any research project that
prospectively assigns human subjects to intervention or
comparison groups to study the cause-and-effect relation-
ship between a medical intervention and a health out-
come. Studies designed for other purposes, such as to
study pharmacokinetics or major toxicity (e.g., phase 1
trials) are exempt.
We do not advocate one particular registry, but regis-
tration must be with a registry that meets the following
minimum criteria:
Accessible to the public at no charge;
Searchable by standard, electronic (Internet-based)
methods;
Open to all prospective registrants free of charge or
at minimal cost;
Validates registered information;
Identifies trials with a unique number; and
Includes information on: the investigator(s), re-
search question or hypothesis, methodology, inter-
vention and comparisons, eligibility criteria, primary
and secondary outcomes measured, date of registra-
C© 2005 by the International Society of Nephrology
tion, anticipated or actual start date, anticipated or
actual date of last follow-up, target number of sub-
jects, status (anticipated, ongoing, or closed), and
funding source(s).
Registries that currently meet these criteria include:
The registry sponsored by the United States National
Library of Medicine (www.clinicaltrials.gov)
The International Standard Randomised Controlled
Trial Number Registry (www.controlled-trials.com)
The Cochrane Renal Group Registry (www.
cochrane-renal.org/trialsubmissionform.php)
The National (United Kingdom) Research
Register(www.update-software.com/national/)
European Clinical Trials Database (http://eudract.
emea.eu.int/)
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